NFKB1 and cancer: Interestingly, miR-1908-5p in turn could downregulate NF-κB activation by binding to an inhibition factor of NF-κB pathway, NF-κB inhibitor interacting Ras-like 2 (NKIRAS2), resulting in elevating cancer cell proliferation and metastatic potential (52).